Characterization of prostanoid receptors mediating actions of the isoprostanes, 8-iso-PGE(2) and 8-iso-PGF(2alpha), in some isolated smooth muscle preparations

Br J Pharmacol. 2000 Aug;130(8):1903-10. doi: 10.1038/sj.bjp.0703522.

Abstract

We investigated the contracting actions of the isoprostanes (isoPs), 8-iso-prostaglandin (PG) F(2alpha) and 8-iso-PGE(2), in comparison to the effects of the thromboxane (TX) A(2)-mimetic U 46619 and the traditional prostaglandin PGE(2) in the isolated rat aorta, isolated rat gastric fundus and the isolated guinea-pig ileum. U 46619 and 8-iso-PGF(2alpha) caused contractions in the rat aorta and rat gastric fundus in a concentration-dependent manner, whereas these agonists showed no effects in the guinea-pig ileum. However, 8-iso-PGE(2) and PGE(2) caused contractions in all isolated organs used. The prostanoid TP-receptor antagonist SQ 29,548 (10 nM) significantly antagonized vasoconstrictions induced by the agonists used in the rat aorta. SQ 29,548 at a final concentration of 3 microM, but not at lower concentrations, significantly inhibited contractions induced by U 46619, 8-iso-PGF(2alpha) and 8-iso-PGE(2) in the rat fundus. Responses to PGE(2) were unchanged. The prostanoid EP(1)-receptor antagonist SC 51089 (3 microM) significantly inhibited contractions induced by 8-iso-PGE(2) and PGE(2) in the rat fundus and in the guinea-pig ileum. SC 51089 had no effect on responses to any of the agonists tested. Our results show that 8-iso-PGE(2), in contrast to 8-iso-PGF(2alpha), can also cause contractions by activation of the EP(1)-receptors in the rat gastric fundus and the guinea-pig ileum. The findings of the present study do not support the existence of a unique isoP-receptor in the tissues used.

MeSH terms

  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid / pharmacology
  • Animals
  • Aorta, Thoracic / drug effects
  • Aorta, Thoracic / physiology
  • Bridged Bicyclo Compounds, Heterocyclic
  • Dinoprost / analogs & derivatives
  • Dinoprost / pharmacology*
  • Dinoprostone / analogs & derivatives*
  • Dinoprostone / pharmacology*
  • Dioxanes / pharmacology
  • Dose-Response Relationship, Drug
  • F2-Isoprostanes
  • Fatty Acids, Unsaturated
  • Female
  • Gastric Fundus / drug effects
  • Gastric Fundus / physiology
  • Guinea Pigs
  • Hydrazines / pharmacology
  • Ileum / drug effects
  • Ileum / physiology
  • In Vitro Techniques
  • Isoprostanes*
  • Muscle Contraction / drug effects
  • Muscle, Smooth / drug effects*
  • Muscle, Smooth / physiology
  • Oxazepines / pharmacology
  • Prostaglandin Antagonists / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Prostaglandin / antagonists & inhibitors
  • Receptors, Prostaglandin / physiology*
  • Receptors, Prostaglandin E / antagonists & inhibitors
  • Receptors, Prostaglandin E, EP1 Subtype
  • Receptors, Thromboxane / antagonists & inhibitors
  • Vasoconstriction / drug effects
  • Vasoconstrictor Agents / pharmacology

Substances

  • Bridged Bicyclo Compounds, Heterocyclic
  • Dioxanes
  • F2-Isoprostanes
  • Fatty Acids, Unsaturated
  • Hydrazines
  • Isoprostanes
  • Oxazepines
  • Prostaglandin Antagonists
  • Ptger1 protein, rat
  • Receptors, Prostaglandin
  • Receptors, Prostaglandin E
  • Receptors, Prostaglandin E, EP1 Subtype
  • Receptors, Thromboxane
  • Vasoconstrictor Agents
  • ICI 192605
  • SC 51089
  • 8-epi-prostaglandin F2alpha
  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
  • SQ 29548
  • Dinoprost
  • Dinoprostone
  • 8-isoprostaglandin E2